NewVale Capital is a growth equity investment firm focused on supporting the services architecture underpinning the life science industry. Our firm invests in proven, revenue-generating services businesses across the life science ecosystem that are helping to bring the next generation of medicines to patients. Our team comprises veteran life science investors, company builders, and pharmaceutical executives with decades of global pharmaceutical industry experience. With our capacity to provide ample capital, our heritage as company builders, and our expansive networks across the pharmaceutical industry, we've designed NewVale to be a valued partner for management teams looking to accelerate their growth.
Visit Company Website
